Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00537797 · ClinicalTrials.gov registry record · NA
Accuracy of FDG-PET Scanning to Diagnose Malignant Thyroid Nodules
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
NCT00537797 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 84 participants.
The verdict
NCT00537797, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
Study Summary
The main purpose of this study is to see how well FDG-PET scans can determine the malignancy of thyroid nodules that have already been tested (and come back positive) by fine needle aspiration.
Interventions
- OTHER FDG-PET Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2004-08 |
| Est. Completion | 2014-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00537797
The ClinicalTrials.gov registry entry for NCT00537797 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FDG-PET Scan is the first listed.
NCT00537797 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00537797 about?
NCT00537797 is a clinical study titled "Accuracy of FDG-PET Scanning to Diagnose Malignant Thyroid Nodules". The main purpose of this study is to see how well FDG-PET scans can determine the malignancy of thyroid nodules that have already been tested (and come back positive) by fine needle aspiration.
What is the current status of trial NCT00537797?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2004-08. Estimated completion is 2014-02.
What interventions are being tested in trial NCT00537797?
The interventions under investigation include: FDG-PET Scan (OTHER).
Who is sponsoring clinical trial NCT00537797?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.